Bellerophon Therapeutics, Inc. Made Headway
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) soared at $2.29, representing a gain of 160.2%. On Thu, Jan 05, 2023, BLPH:NASDAQ hit a New 2-Week High of $2.29. The stock appeared on our News Catalysts scanner on Thu, Jan 05, 2023 at 10:43 AM in the 'AGREEMENT' category. From Thu, Dec 22, 2022, the stock recorded 62.50% Up Days and 44.44% Green Days
The stock spiked on Thu, Jan 05, 2023 at $3.5 with a volume of 58M+.
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 199.5%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 160.2%
- Magic Empire Global Limited (MEGL:NASDAQ), 75.57%
- NovoCure Limited (NVCR:NASDAQ), 68.45%
- TIAN RUIXIANG Holdings Ltd (TIRX:NASDAQ), 58.54%
- Vyant Bio Inc. (VYNT:NASDAQ), 57.18%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 47.06%
- Zai Lab Limited (ZLAB:NASDAQ), 41.8%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 34.63%
- Argo Blockchain plc (ARBK:NASDAQ), 33.33%